Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.

NCT00742495 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Slow Recruitment

Conditions

Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia
B-cell Precursor Acute Lymphoblastic Leukaemia
T-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: Forodesine

Sponsor

Mundipharma Research Limited

Collaborators

[object Object]